Where is Envisagenics headquartered?

Envisagenics is located in New York, NY.

Who invested in Envisagenics?

Envisagenics has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Envisagenics?

Envisagenics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

envisagenics.com

Envisagenics

Envisagenics is a New York-based AI platform that provides solutions such as RNA therapeutics development and target identification for the pharmaceutical sector.

Business Model:

Revenue: $2.2M

Employees: 11-50

Geographic Data

Address: 101 Avenue of the Americas

City: New York

State: NY

Zip: 10013

Country: US

Financial Info

Stage:

grant

Raised Last:

$2M

Raised Total:

$5M

Social

Facebook

Twitter

Crunchbase

Metrics

8,023,501Website Global Rank

405Website Monthly Traffic

Twitter Followers

Description

Envisagenics is a New York-based AI platform that provides solutions such as RNA therapeutics development and target identification for the pharmaceutical sector.

Contact Phone:
+19297772001

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2017	Seed		$2.5M	Dynamk Capital
11/2017	Seed Round	6	$2.4M	Dynamk Capital New York State Third Kind Venture Capital SV Angel Dolby Family Ventures Cosine Dynamk Capital
9/2021	Series A		-
7/2015	Debt Financing	2	$100k	Accelerate Long Island the Long Island Emerging technologies Fund (LIETF)
5/2020	Debt		$150k	U.S. Small Business Administration.
7/2016	Non Equity Assistance	1	-	Grand Central Tech Grand Central Tech
10/2019	Grant	1	$300k	National Cancer Institute National Cancer Institute
5/2018	Grant	1	$1.5M	National Institutes of Health National Institutes of Health
5/2018	Seed Round	2	$1M	M12 - Microsoft&s;s Venture Fund Madrona Venture Group M12 - Microsoft&s;s Venture Fund Madrona Venture Group
9/2021	Series A	6	$19.2M	Dynamk Capital M12 - Microsoft&s;s Venture Fund Madrona Venture Group New York Ventures Red Cell Partners Third Kind Venture Capital Dynamk Capital M12 - Microsoft&s;s Venture Fund Madrona Venture Group New York Ventures Red Cell Partners Third Kind Venture Capital
4/2017	Grant		$0	The Thiel Foundation The Thiel Foundation
8/2015	Grant	1	$225k	National Institutes of Health
8/2022	Grant	1	$2M	National Cancer Institute National Cancer Institute
9/2021	Series A		-	Red Cell Partners M12 Madrona Venture Group Third Kind Venture Capital Dynamk Capital Red Cell Partners M12 Madrona Venture Group Third Kind Venture Capital Dynamk Capital
4/2017	Grant	1	$350k
7/2016	Non Equity Assistance	1	-	Grand Central Tech Grand Central Tech

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details